Get the Stockscreener App
5.56
9.23%
0.47
Pepgen Inc stock is traded at $5.56, with a volume of 1.83M.
It is up +9.23% in the last 24 hours and up +13.93% over the past month.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
See More
Previous Close:
$5.09
Open:
$5.16
24h Volume:
1.83M
Relative Volume:
0.64
Market Cap:
$382.24M
Revenue:
-
Net Income/Loss:
$-87.23M
P/E Ratio:
-1.8721
EPS:
-2.97
Net Cash Flow:
$-82.77M
1W Performance:
+17.30%
1M Performance:
+13.93%
6M Performance:
+286.11%
1Y Performance:
+28.70%
1-Day Range:
$5.04
$5.74
1-Week Range:
$4.75
$5.97
52-Week Range:
$0.8801
$6.85
Pepgen Inc Stock (PEPG) Company Profile
Name
Pepgen Inc
Sector
Industry
Phone
703-456-8000
Address
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Compare PEPG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PEPG
Pepgen Inc
|
5.56 | 349.93M | 0 | -87.23M | -82.77M | -2.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-09-25 | Initiated | Guggenheim | Buy |
| Dec-16-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-21-22 | Initiated | H.C. Wainwright | Buy |
Pepgen Inc Stock (PEPG) Latest News
Can PepGen Inc. stock beat analyst upgradesMarket Activity Recap & Long-Term Growth Portfolio Plans - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against PepGen Inc. (PEPG) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Why retail investors pile into PepGen Inc. stockDividend Hike & Safe Capital Growth Stock Tips - newser.com
Will PepGen Inc. price bounce be sustainable2025 Growth vs Value & Low Risk Profit Maximizing Plans - newser.com
What risks investors should watch in PepGen Inc. stockMarket Performance Report & Capital Protection Trading Alerts - newser.com
PepGen Inc. (PEPG) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Bronstein, Gewirtz & Grossman, LLC Is Investigating PepGen Inc. (PEPG) And Encourages Stockholders to Connect - ACCESS Newswire
PepGen Investor Drops Suit Over Muscular Dystrophy Drug Study - news.bloomberglaw.com
Can PepGen Inc. stock attract ESG capital inflows2025 Trading Volume Trends & Safe Entry Momentum Stock Tips - newser.com
Will PepGen Inc. see short term momentumShort Setup & Safe Entry Momentum Stock Tips - newser.com
Smart tools for monitoring PepGen Inc.’s price actionPortfolio Update Summary & AI Powered Trade Plan Recommendations - newser.com
Advanced analytics toolkit walkthrough for PepGen Inc.2025 Volatility Report & Stepwise Swing Trade Plans - newser.com
Will PepGen Inc. continue its uptrend2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com
Tools to monitor PepGen Inc. recovery probabilityShare Buyback & Low Drawdown Momentum Ideas - newser.com
Is PepGen Inc. stock trading near support levelsJuly 2025 Big Picture & Weekly High Return Stock Forecasts - newser.com
PepGen (PEPG) Price Target Increased by 17.65% to 10.20 - Nasdaq
Bronstein, Gewirtz & Grossman, LLC Is Investigating PepGen Inc. (PEPG) And Encourages Investors to Connect - ACCESS Newswire
Will PepGen Inc. stock see insider buyingEarnings Overview Report & Safe Investment Capital Preservation Plans - newser.com
PepGen price target raised to $20 from $18 at H.C. Wainwright - MSN
PepGen reports Q3 EPS (52c), consensus (56c) - MSN
PepGen Inc.'s (NASDAQ:PEPG) largest shareholders are individual investors with 39% ownership, private equity firms own 36% - Yahoo Finance
PepGen Inc.Common Stock (NQ: PEPG - FinancialContent
What analysts say about PepGen Inc stockPrice Action Trading & Small Budget Capital Gains - earlytimes.in
Will PepGen Inc. stock sustain high P E ratiosJuly 2025 Summary & High Return Trade Guides - Fundação Cultural do Pará
HC Wainwright & Co. Maintains PepGen (PEPG) Buy Recommendation - Nasdaq
Wedbush Raises Price Target on PepGen to $9 From $8, Keeps Outperform Rating - MarketScreener
PepGen Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights - BioSpace
PepGen Narrows Losses And Advances Myotonic Dystrophy Research - Finimize
Pepgen Inc Stock (PEPG) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):